Organovo Up 19% Pre-Market; In Research Pact WIth J&J Unit

Organovo Holdings Inc.

shares rose 19 percent in pre-market action Thursday when the company unveiled a research agreement with a unit of Johnson & Johnson

. https://www.sec.gov/Archives/edgar/data/1497253/000119312514277960/d764182d8k.htm Terms weren't disclosed. In the pact, Oranovo will help Johnson & Johnson's Janssen Research and Development unit to evaluate 3D bio-printed tissue in a drug discovery setting. The work excludes Organovo's work in 3D liver tissue for toxicity testing. Organovo was formed in 2012 from the shell company Real Estate Restoration and Rental Inc. It seeks to commercialize technology for manufacturing human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants. In pre-market trading Organovo changed hands recently at $9.10, up 18.95 percent.